Fixing essential medicine shortages: obstacles and opportunities
Global health experts and governing bodies agree that everyone has a right to access the medicines they need. The COVID-19 pandemic and...
top of page
Search
Kristy Hawkins
- Mar 22, 2021
Investing in the next wave of biomanufacturing technologies for pharma
The global pandemic has brought pharmaceutical manufacturing to the forefront of America’s public consciousness. Acute drug shortages...
Christina Smolke
- Oct 13, 2020
Antheia at SynBioBeta 2020
Earlier this month, my cofounder Kristy Hawkins and I presented at SynBioBeta 2020, the flagship conference for the synthetic biology...
Christina Smolke
- Jul 16, 2020
As Featured in STAT: The pharma supply chain is broken. Synthetic biology could fix it.
COVID-19 has exposed the frailties of the international pharma supply chain and as the pandemic continues to spread, we are seeing the mount
Christina Smolke
- Jun 22, 2020
The Journey of a Pill
Americans spend over $300 billion on pharmaceutical drugs every year. In normal times, the supply chain behind these drugs is designed to...
Antheia Newsroom
bottom of page